# Institute of Regenerative and Cellular Medicine – FDA Inspection, Jan 12, 2016

Source: https://www.keypedia.com/records/fda_inspections/institute-of-regenerative-and-cellular-medicine/59f356e7-78c4-4d09-a801-c75ea61a758d
Source feed: FDA_Inspections

> FDA inspection 950164 of Institute of Regenerative and Cellular Medicine, January 12, 2016. Classification: Voluntary Action Indicated (VAI). 7 citations under 21 CFR part 56. 1 other FDA inspection on record for this company.

---

## Details

- Record Type: FDA Inspection
- Inspection ID: 950164
- Company Name: Institute of Regenerative and Cellular Medicine
- Inspection Date: 2016-01-12
- Classification: Voluntary Action Indicated (VAI)
- Classification Code: VAI
- Project Area: Bioresearch Monitoring
- Product Type: Biologics
- Center: Biologics
- Office Name: Center for Biologics Evaluation and Research
- Citation Count: 7

## Related Documents

- [FDA Inspection 1155145 - 2021-10-19](https://www.keypedia.com/records/fda_inspections/institute-of-regenerative-and-cellular-medicine/0c8e5f6e-7c9c-4576-bab0-dd2e6893647c)

Company: https://www.keypedia.com/companies/institute-of-regenerative-and-cellular-medicine/09a4f8e2-c062-4f0b-8e9a-54de69b7d6bf

Office: https://www.keypedia.com/offices/center-for-biologics-evaluation-and-research/dd9e8ea7-6f04-4ed1-b0d7-e7e6b264570d
